» Articles » PMID: 22664739

Klotho As a Potential Biomarker and Therapy for Acute Kidney Injury

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2012 Jun 6
PMID 22664739
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Klotho is a single-pass transmembrane protein that is highly expressed in the kidney and is known to act as a coreceptor for fibroblast growth factor 23. The extracellular domain can be produced independently or shed from membrane-bound Klotho and functions as an endocrine substance with multiple functions including antioxidation, modulation of ion transport, suppression of fibrosis, and preservation of stem cells. Emerging evidence has revealed that Klotho deficiency is an early event in acute kidney injury (AKI), and a pathogenic factor that exacerbates acute kidney damage and contributes to long-term consequences. Restoration by exogenous supplementation or stimulation of endogenous Klotho might prevent and ameliorate injury, promote recovery, and suppress fibrosis to mitigate development of chronic kidney disease. Although data are still emerging, in this Perspectives article we discuss why this renal-derived protein is a highly promising candidate as both an early biomarker and therapeutic agent for AKI.

Citing Articles

Obesity-Related Chronic Kidney Disease: From Diagnosis to Treatment.

Avgoustou E, Tzivaki I, Diamantopoulou G, Zachariadou T, Avramidou D, Dalopoulos V Diagnostics (Basel). 2025; 15(2).

PMID: 39857056 PMC: 11763674. DOI: 10.3390/diagnostics15020169.


αKlotho modulates BNIP3-mediated mitophagy by regulating FoxO3 to decrease mitochondrial ROS and apoptosis in contrast-induced acute kidney injury.

Zhu X, Lin Q, Yang Y, Li S, Shao X, Zhang W Cell Mol Life Sci. 2024; 81(1):454.

PMID: 39545953 PMC: 11568077. DOI: 10.1007/s00018-024-05473-z.


Serum Klotho Is Elevated in Patients with Acute Myocardial Infarction and Could Predict Poor In-Hospital Prognosis.

Pei Y, Huang W, Cao L, Yang F, Chi C, Zhu J J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330350 PMC: 11432139. DOI: 10.3390/jcdd11090292.


Sexually dimorphic renal expression of mouse Klotho is directed by a kidney-specific distal enhancer responsive to HNF1b.

Jankowski J, Lee H, Liu C, Wilflingseder J, Hennighausen L Commun Biol. 2024; 7(1):1142.

PMID: 39277686 PMC: 11401919. DOI: 10.1038/s42003-024-06855-6.


Sexually dimorphic renal expression of is directed by a kidney-specific distal enhancer responsive to HNF1b.

Jankowski J, Lee H, Liu C, Wilflingseder J, Hennighausen L Res Sq. 2024; .

PMID: 38712042 PMC: 11071613. DOI: 10.21203/rs.3.rs-4188774/v1.


References
1.
Kurosu H, Choi M, Ogawa Y, Dickson A, Goetz R, Eliseenkova A . Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem. 2007; 282(37):26687-26695. PMC: 2496965. DOI: 10.1074/jbc.M704165200. View

2.
Perco P, Oberbauer R . Kidney injury molecule-1 as a biomarker of acute kidney injury in renal transplant recipients. Nat Clin Pract Nephrol. 2008; 4(7):362-3. DOI: 10.1038/ncpneph0828. View

3.
Zarjou A, Yang S, Abraham E, Agarwal A, Liu G . Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol. 2011; 301(4):F793-801. PMC: 3191802. DOI: 10.1152/ajprenal.00273.2011. View

4.
Ohata Y, Arahori H, Namba N, Kitaoka T, Hirai H, Wada K . Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood. J Clin Endocrinol Metab. 2011; 96(6):E943-7. DOI: 10.1210/jc.2010-2357. View

5.
Pavik I, Jaeger P, Ebner L, Poster D, Krauer F, Kistler A . Soluble klotho and autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011; 7(2):248-57. PMC: 3280025. DOI: 10.2215/CJN.09020911. View